Corrigendum: TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS , STK11 and KEAP1 mutations.

Autor: Frille A; Department of Respiratory Medicine, Leipzig University, Leipzig, Germany., Boeschen M; Institute of Pathology, Leipzig University, Leipzig, Germany., Wirtz H; Department of Respiratory Medicine, Leipzig University, Leipzig, Germany., Stiller M; Institute of Pathology, Leipzig University, Leipzig, Germany., Bläker H; Institute of Pathology, Leipzig University, Leipzig, Germany., von Laffert M; Institute of Pathology, Leipzig University, Leipzig, Germany.
Jazyk: angličtina
Zdroj: Frontiers in oncology [Front Oncol] 2024 Sep 11; Vol. 14, pp. 1473239. Date of Electronic Publication: 2024 Sep 11 (Print Publication: 2024).
DOI: 10.3389/fonc.2024.1473239
Abstrakt: [This corrects the article DOI: 10.3389/fonc.2024.1357583.].
(Copyright © 2024 Frille, Boeschen, Wirtz, Stiller, Bläker and von Laffert.)
Databáze: MEDLINE